FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maria Pirillo

Research Profile

Disorders

Chemicals & Drugs

Living Beings

HIV-1

Procedures

Co-author Network

Publications

TOP 3
Clementina M Galluzzo; Roberta Amici; Mauro Andreotti; Susanna Ceffa; Fulvio Erba; Haswell Jere; Giuseppe Liotta; Richard Luhanga; Sandro Mancinelli; Maria Cristina Marazzi; Martin Maulidi; leonardo Palombi; Maria F Pirillo; Jean-Baptiste Sagno; Stefano Vella; Marina Giuliano
Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
Raffaella Bucciardini; G Ceccarelli; O Cirioni; A Degli Antoni; Gabriella d'Ettorre; Marco Floridia; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; G Guaraldi; Nicoletta Ladisa; S Lucattini; P E Manconi; Giustino Parruti; Maria F Pirillo; R Preziosi; G Verucchi; V Vullo; Liliana E Weimer; Silvia Baroncelli; Rita Bellagamba
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.
Silvia Baroncelli; Raffaella Bucciardini; Albertina Cavalli; Anna Degli Antoni; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; Nicoletta Ladisa; Alessandra Mercuri; Laura Monno; Maria F Pirillo; Anna Volpe; Liliana E Weimer; Marco Floridia
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maria Pirillo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Clementina M Galluzzo; Roberta Amici; Mauro Andreotti; Susanna Ceffa; Fulvio Erba; Haswell Jere; Giuseppe Liotta; Richard Luhanga; Sandro Mancinelli; Maria Cristina Marazzi; Martin Maulidi; leonardo Palombi; Maria F Pirillo; Jean-Baptiste Sagno; Stefano Vella; Marina Giuliano
Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
Journal of medical virology 2012;84(10):1553-7.
2012: Raffaella Bucciardini; G Ceccarelli; O Cirioni; A Degli Antoni; Gabriella d'Ettorre; Marco Floridia; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; G Guaraldi; Nicoletta Ladisa; S Lucattini; P E Manconi; Giustino Parruti; Maria F Pirillo; R Preziosi; G Verucchi; V Vullo; Liliana E Weimer; Silvia Baroncelli; Rita Bellagamba
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.
International journal of STD & AIDS 2012;23(7):459-63.
2012: Silvia Baroncelli; Raffaella Bucciardini; Albertina Cavalli; Anna Degli Antoni; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; Nicoletta Ladisa; Alessandra Mercuri; Laura Monno; Maria F Pirillo; Anna Volpe; Liliana E Weimer; Marco Floridia
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.
The Journal of antimicrobial chemotherapy 2012;67(6):1479-85.
2012: leonardo Palombi; Simona Pichini; Maria F Pirillo; Jean-Baptiste Sagno; Stefano Vella; Mauro Andreotti; Susanna Ceffa; Fulvio Erba; Clementina M Galluzzo; Haswell Jere; Giuseppe Liotta; Maria Cristina Marazzi; Emilia Marchei; Martin Maulidi; Marina Giuliano
Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety.
Antiviral therapy 2012;17(8):1511-9.
2011: Maria F Pirillo; Patricia Recordon-Pinson; Roberta Amici; Mauro Andreotti; Maria Grazia Mancini; Marina Giuliano
Quantification of HIV-RNA from dried blood spots using the Siemens VERSANT® HIV-1 RNA (kPCR) assay.
The Journal of antimicrobial chemotherapy 2011;66(12):2823-6.
2010: Maria F Pirillo; Lucia Palmisano; Manuela Pellegrini; Clementina M Galluzzo; Liliana E Weimer; Raffaella Bucciardini; Vincenzo Fragola; Mauro Andreotti; Emilia Marchei; Simona Pichini; STEFANO VELLA; Marina Giuliano
Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.
AIDS research and human retroviruses 2010;26(5):541-5.
2009: Lucia Palmisano; Marina Giuliano; Clementina M Galluzzo; Roberta Amici; Mauro Andreotti; Liliana E Weimer; Maria F Pirillo; Vincenzo Fragola; Raffaella Bucciardini; STEFANO VELLA
The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy.
HIV medicine 2009;10(8):477-81.
2009: Mauro Andreotti; Clementina M Galluzzo; Giovanni Guidotti; Paola Germano; Annamaria Doro Altan; Maria F Pirillo; Maria Cristina Marazzi; STEFANO VELLA; leonardo Palombi; Marina Giuliano
Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique.
AIDS research and human retroviruses 2009;25(7):707-11.
2008: Silvia Baroncelli; Paola Villani; Marco Floridia; Maria F Pirillo; Clementina M Galluzzo; Maria Cusato; Roberta Amici; Carmela Pinnetti; Francesca Sabbatini; Atim Molinari; Enrica Tamburrini; Mario Regazzi
Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.
Therapeutic drug monitoring 2008;30(5):604-10.
2008: Lucia Palmisano; Marina Giuliano; Flavia Chiarotti; Marisa Zanchetta; Mauro Andreotti; Maria F Pirillo; Elisabetta Riva; Guido Antonelli; Anita De Rossi; STEFANO VELLA
Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2008;48(1):68-71.
2008: Silvia Baroncelli; Mauro Andreotti; Giovanni Guidotti; Maria F Pirillo; Susanna Ceffa; Maria Grazia Mancini; Paola Germano; Maria Cristina Marazzi; STEFANO VELLA; leonardo Palombi; Marina Giuliano
Tumor necrosis factor-alpha, Interleukin-10, and alpha-defensins in plasma and breast milk of HIV-infected highly active antiretroviral therapy-treated and untreated pregnant women in Mozambique.
Journal of acquired immune deficiency syndromes (1999) 2008;47(5):647-9.
2007: Maria F Pirillo; Luciana Bassani; Elena A P Germinario; Maria Grazia Mancini; Joseph Vyankandondera; Pius Okong; STEFANO VELLA; Marina Giuliano
Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda.
Journal of medical virology 2007;79(12):1797-801.
2007: Mauro Andreotti; Giovanni Guidotti; Clementina M Galluzzo; Sandro Mancinelli; Paola Germano; Maria F Pirillo; Maria Cristina Marazzi; STEFANO VELLA; leonardo Palombi; Marina Giuliano
Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention.
AIDS (London, England) 2007;21(17):2360-2.
2007: Lucia Palmisano; Marina Giuliano; Raffaella Bucciardini; Vincenzo Fragola; Mauro Andreotti; Clementina M Galluzzo; Maria F Pirillo; Liliana E Weimer; Romano Arcieri; Elena A P Germinario; Roberta Amici; Maria Grazia Mancini; Antonella d'Arminio Monforte; Francesco Castelli; Pietro Caramello; STEFANO VELLA
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) study.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):39-47.
2007: Marina Giuliano; Giovanni Guidotti; Mauro Andreotti; Maria F Pirillo; Paola Villani; Giuseppe Liotta; Maria Cristina Marazzi; Maria Grazia Mancini; Maria Cusato; Paola Germano; Sandra Loureiro; Susanna Ceffa; Mario Regazzi; STEFANO VELLA; leonardo Palombi
Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.
Journal of acquired immune deficiency syndromes (1999) 2007;44(3):286-91.
2006: Paola Villani; Marco Floridia; Maria F Pirillo; Maria Cusato; Enrica Tamburrini; A F Cavaliere; G Guaraldi; C Vanzini; A Molinari; A degli Antoni; Mario Regazzi
Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.
British journal of clinical pharmacology 2006;62(3):309-15.
2005: Lucia Palmisano; Marina Giuliano; Emanuele Nicastri; Maria F Pirillo; Mauro Andreotti; Clementina M Galluzzo; Raffaella Bucciardini; Vincenzo Fragola; Massimo Andreoni; STEFANO VELLA
Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy.
AIDS (London, England) 2005;19(16):1843-7.
2004: Marco Floridia; Raffaella Bucciardini; Vincenzo Fragola; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Roberta Amici; Mauro Andreotti; D Ricciardulli; C Tomino; STEFANO VELLA
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL).
HIV medicine 2004;5(1):1-10.
2003: Simonetta Di Fabio; Jens Van Roey; Giacomo Giannini; Guy Van den Mooter; Massimo Spada; Andrea Binelli; Maria F Pirillo; Elena Germinario; Filippo Belardelli; Marie-Pierre de Bethune; STEFANO VELLA
Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation.
AIDS (London, England) 2003;17(11):1597-604.
2002: Marco Floridia; Vincenzo Fragola; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; C Tomino; STEFANO VELLA
HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trial.
HIV medicine 2002;3(2):75-84.
2000: Marco Floridia; C Tomino; Raffaella Bucciardini; D Ricciardulli; Vincenzo Fragola; Maria F Pirillo; Roberta Amici; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; AC Seeber; Adriana Ammassari; A Cingolani; Adriano Lazzarin; G Scalise; Antonietta Cargnel; Fredy Suter; F Milazzo; G Pastore; Mauro Moroni; R Ciammarughi; R Pini; Giampiero Carosi; C D'Amato; L Contu; Ercole Concia; L Bonazzi; Fernando Aiuti; Gianmarco Vigevani; STEFANO VELLA
A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.
AIDS research and human retroviruses 2000;16(17):1809-20.
2000: Raffaella Bucciardini; Albert W Wu; Marco Floridia; Vincenzo Fragola; D Ricciardulli; C Tomino; Liliana E Weimer; Maria F Pirillo; Marco Mirra; MAURO MARZI; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; Maurizio Massella; STEFANO VELLA
Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients.
AIDS (London, England) 2000;14(16):2567-74.
2000: Marco Floridia; Maurizio Massella; Raffaella Bucciardini; C A Perucci; L Rossi; C Tomino; Vincenzo Fragola; D Ricciardulli; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; Marco Mirra; STEFANO VELLA
Hospitalizations and costs of treatment for protease inhibitor-based regimens in patients with very advanced HIV-infection (CD4 < 50/mm(3)).
HIV clinical trials 2000;1(2):9-16.
2000: STEFANO VELLA; Mariangela Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; C Tomino; Vincenzo Fragola; Raffaella Bucciardini; D Ricciardulli; Andrea Binelli; Liliana E Weimer; Marco Floridia
Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment.
Antiviral research 2000;47(3):189-98.
2000: Kristien Van Vaerenbergh; Kristel Van Laethem; J Albert; C A Boucher; Bonaventura Clotet; Marco Floridia; J Gerstoft; B Hejdeman; C Nielsen; Christophe Pannecouque; L Perrin; Maria F Pirillo; Lidia Ruiz; Jean-Claude Schmit; F Schneider; A Schoolmeester; R Schuurman; Hans-Jürgen Stellbrink; Lieven Stuyver; Jan van Lunzen; Barbara Van Remoortel; Eric Van Wijngaerden; STEFANO VELLA; Myriam Witvrouw; S Yerly; Erik De Clercq; J Destmyer; Anne-Mieke Vandamme
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues.
Antimicrobial agents and chemotherapy 2000;44(8):2109-17.
2000: Alessandra Vigano; STEFANO VELLA; Marina Saresella; Angelo Vanzulli; Dorella Bricalli; S Di Fabio; Pasquale Ferrante; M Andreotti; Maria F Pirillo; LG Dally; Mario Clerici; Nicola Principi
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.
AIDS (London, England) 2000;14(3):251-61.
1999: Alessandra Viganò; LG Dally; Dorella Bricalli; N Sala; Maria F Pirillo; Marina Saresella; Daria Trabattoni; STEFANO VELLA; Mario Clerici; Nicola Principi
Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection.
The Journal of pediatrics 1999;135(6):675-82.
1999: Marco Floridia; Raffaella Bucciardini; D Ricciardulli; Vincenzo Fragola; Maria F Pirillo; Liliana E Weimer; C Tomino; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; Antonietta Cargnel; Francesco Alberici; B De Rienzo; Francesco Leoncini; F Fiaccadori; Daniela Francisci; W Grillone; L Ortona; M Piazza; A Scalzini; E Nigra; F Tumietto; STEFANO VELLA
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(1):11-9.
1997: Caterina Lapenta; Stefano Fais; Paola Rizza; Massimo Spada; Mariantonia Logozzi; Stefania Parlato; Stefano M Santini; Maria F Pirillo; Filippo Belardelli; Enrico Proietti
U937-SCID mouse xenografts: a new model for acute in vivo HIV-1 infection suitable to test antiviral strategies.
Antiviral research 1997;36(2):81-90.
1997: Marta Carlesimo; O Pontesilli; EC Guerra; A R Varani; Maria Livia Bernardi; G Ricci; Cecilia Alario; Maria F Pirillo; G Mattiacci; P Leone; Antonio Cassone; Fernando Aiuti
Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected persons.
The Journal of infectious diseases 1997;176(4):904-12.
1997: Massimo Andreoni; Loredana Sarmati; Lucia Ercoli; Emanuele Nicastri; Giacomo Giannini; Clementina M Galluzzo; Maria F Pirillo; STEFANO VELLA
Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy.
AIDS research and human retroviruses 1997;13(7):555-61.
1996: STEFANO VELLA; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; I Duncan; H Jacobsen; Massimo Andreoni; Loredana Sarmati; Lucia Ercoli
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.
Antiviral research 1996;29(1):91-3.